Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 10.50
0.00 (0.00%)
Aug 14, 2026, 4:11 PM GMT
Fusion Antibodies Cash Flow Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | -1.47 | -1.71 | -2.23 | -2.6 | -1.2 | -2.9 |
Depreciation & Amortization | 0.11 | 0.11 | 0.22 | 0.37 | 0.75 | 0.71 |
Other Amortization | - | - | - | - | 0 | 0 |
Stock-Based Compensation | 0.01 | 0.04 | 0.09 | 0.04 | 0.02 | 0.02 |
Other Operating Activities | 0.15 | 0.04 | 0.22 | -0.13 | -0.02 | 1.72 |
Change in Accounts Receivable | -0.2 | -0.08 | 0.13 | 0.82 | -0.08 | -0.55 |
Change in Inventory | -0.04 | 0.19 | 0.08 | 0.05 | -0.11 | -0.14 |
Change in Accounts Payable | 0.26 | 0.05 | -0.28 | -0.3 | 0.31 | 0.01 |
Operating Cash Flow | -1.18 | -1.36 | -1.77 | -1.75 | -0.33 | -1.14 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Capital Expenditures | -0.07 | -0.01 | -0 | -0.11 | -0.26 | -0.37 |
Other Investing Activities | 0 | 0.01 | 0 | 0 | 0 | 0 |
Investing Cash Flow | -0.07 | -0.01 | 0 | -0.11 | -0.26 | -0.36 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Long-Term Debt Issued | - | - | - | 0.07 | - | 0.01 |
Long-Term Debt Repaid | - | -0.02 | -0.03 | -0.06 | -0.16 | -0.16 |
Net Debt Issued (Repaid) | -0.05 | -0.02 | -0.03 | 0.01 | -0.16 | -0.15 |
Issuance of Common Stock | 1.12 | 0.56 | 2.81 | - | 0.12 | 3.02 |
Other Financing Activities | -0.01 | -0 | -0.01 | -0 | -0.01 | -0.22 |
Financing Cash Flow | 1.06 | 0.53 | 2.77 | 0 | -0.06 | 2.65 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Foreign Exchange Rate Adjustments | -0 | - | 0 | 0.01 | 0.01 | - |
Net Cash Flow | -0.19 | -0.84 | 1 | -1.85 | -0.64 | 1.15 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Free Cash Flow | -1.25 | -1.37 | -1.77 | -1.87 | -0.59 | -1.5 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -78.26% | -69.92% | -155.90% | -64.39% | -12.25% | -36.04% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.07 | -0.02 | -0.06 |
Levered Free Cash Flow | -0.78 | -0.75 | -0.97 | -1.08 | -0.22 | -1.17 |
Unlevered Free Cash Flow | -0.77 | -0.75 | -0.97 | -1.07 | -0.22 | -1.16 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash Interest Paid | 0.01 | 0 | 0.01 | 0 | 0.01 | 0.02 |
Cash Income Tax Paid | - | -0.11 | -0.28 | -0.13 | -0.1 | -0.07 |
Change in Working Capital | 0.02 | 0.17 | -0.07 | 0.57 | 0.12 | -0.69 |